Using telemedicine for older cancer patients
Official title: Deployment of Teleconsulting in Geriatric Oncology for Patients Aged 75years or Older Initiating an Oncologic Treatment and Living in Remote Area With no or Few Access to Geriatric Oncology Evaluation Nearby Their Oncologic Treatment Center
Run by Assistance Publique Hopitaux De Marseille · NCT05619731 · Data updated 2026-11-12
This study is testing if virtual doctor visits can help older cancer patients get better care and avoid unnecessary hospital stays.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 75 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Assistance Publique Hopitaux De Marseille Academic / other |
| Locations | 1 site (Avignon) |
| Status | Recruiting |
| Started | October 18, 2023 |
| Main results expected | November 18, 2026 |
| Study ends | May 18, 2027 |
| Registry record updated | February 4, 2026 |
| Trial ID | NCT05619731 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 75 and older who are diagnosed with any type or stage of cancer and are willing to undergo a geriatric oncology assessment.
✕Probably not a fit
Patients with severe cognitive impairments, significant language barriers, or those unable to consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of teleconsultations in geriatric oncology for older patients with cancer. It focuses on conducting Comprehensive Geriatric Assessments (CGA) remotely to improve treatment management and reduce unexplained re-hospitalization rates. The study aims to address the limited access to specialized care for older adults in rural areas of France, particularly in light of the COVID-19 pandemic. By integrating pharmaceutical expertise into the CGA, the study seeks to enhance patient safety and treatment outcomes.
Why it matters
Potential benefit: If successful, this approach could significantly improve the management and outcomes of older cancer patients by providing better access to specialized care.
How similar studies have gone: Other studies have shown promising results with telemedicine in improving access to care for older adults, making this approach both relevant and timely.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 75 years and older * Suffering from all types and all stages of cancer and treated for cancer in participating centers * G8 (screening tool) ≤ 14/17 * Agreeing to benefit from a geriatric oncology assessment * Having signed a consent * Affiliated to French social security or a similar French solidarity scheme Exclusion Criteria: * Patients under guardianship or curatorship or inability to sign consent * Patients with severe cognitive impairment (MMSE \< 10/30) * Patients with severe hearing or visual impairments as these patients will have difficulty performing the telemedicine consultation * Patients with a significant language barrier without an interpreter present because these patients will have difficulty carrying out the Telemedicine consultation * Patients with expectancy less than 3 months
Where it's running
-
CH Avignon
Avignon, France Recruiting
Study contacts
- Principal investigator: Anne-Laure COUDERC — Assistance Publique des Hôpitaux de Marseille (AP-HM)
- Study coordinator: Clement Pierre
- Email: clement.pierre@ap-hm.fr
- Phone: +33491435796
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cryopreserved autologous SVF plus micrograft for refractory ano-perineal fistulas in Crohn's disease
This trial tests whether thawed stromal vascular fraction (SVF) injected around fistulas can help Crohn’s patients who haven’t responded to prior therapy.
-
Prevention of Recidivism and Better Care for Women Seeking Asylum Who Endure Sexual Violence
This study tests a coordinated care model to support adult women seeking asylum in France who have experienced sexual violence, with the aim of improving health and quality of life.
-
Transition to adulthood for young adults with severe haemophilia
This study tests how young adults with severe haemophilia who were in TRANSHEMO as teens are faring as they move into adulthood.
-
Biomarkers of Response to SEEG Thermocoagulation
This study tests biomarkers to see if they predict how well SEEG-guided radiofrequency thermocoagulation helps people with drug-resistant focal epilepsy.
-
Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain
This project will try advanced 3T and 7T MRI scans, including sodium and phosphorus imaging, to see if metabolic and connectivity changes explain resilience and degeneration in adults with MS, NMOSD, MOGAD, Alzheimer’s, Parkinson’s, or healthy aging.
-
Predicting immune-related side effects in solid cancers treated with immune therapy
This study tests whether a baseline biological signature can predict immune-related adverse events in adults with solid tumors who are starting immune checkpoint inhibitors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.